Top Tweets for #CIOabcd
Spectacular start into the First Session of our joint #cioabcd Symposium on systemic cancer biology and #metastasis today at #cioabcd with a great Talk by @HolzelMichael …
Beautifull Talk by Margherita Vieri from @UniklinikAachen on the role of megakaryocytes in #CML at #ESHCML2025 in Estoril #cioabcd @ESHaematology @SchemionekM
Herzliche Einladung zu nächsten #CIO-connect Veranstaltung des #cioabcd zum Thema #MPN und #CML am 12. März nach Aachen !!! @UniklinikAachen @UKKoeln @UniklinikDUS @UniklinikBonn
Are you interested in the novel #testis #cancer #biomarker #microRNA 371? Read our joined research article of the #CIO-B and #CIO-D on its role in #cisplatin #resistance…
@UniklinikDUS
@HHU_de
@UniBonn
@DGUrologie
@MaGIC_GCT
#CIOABCD
https://t.co/aSSuJmL8ue
Strong participation and great scientific contributions from @UniklinikAachen #cioabcd at this years’ #ESHBMFS2024 conference on bone marrow failure and cancer predisposition syndromes. What a dedicated team of great people! 😊🙏👏 @ESHaematology
Steffen Koschmieder from @UniklinikAachen #cioabcd speaking about mechanisms underlying germline predisposition to #MPN at #ESHBMFS2024 by @ESHaematology with @TheEBMT and @EHA_Hematology @GsgMpn 🙏 to #CRU344 by @dfg_public
Our recent Review on #telomere biology disorders (#TBD) now available in Open Access! Congratulations and 🙏 to @DrRolles ! More to learn about this topic and #BMFS in general at #ESHBMFS2024 this November in Paris !!! @ESHaematology #cioabcd https://t.co/SUkkPwdX5w
Excellent talk by Julian Baumeister, member of #CRU344 @UniklinikAachen by @dfg_public on his project on #MPN within the #cioabcd Mildred Scheel School of Oncology @MSSOabcd at it’s ann. Meeting. Big 🙏 to @Krebshilfe_Bonn @GsgMpn
Join us for excellent Scientific and Clinical exchange on bone marrow failure syndromes at #ESHBMFS2024 in Paris, 🇫🇷 SCHOLARSHIPS ARE STILL AVAILABLE: ONE WEEK LEFT TO APPLY!: https://t.co/E0IM7Ko8ip #telomere #cioabcd @ESHaematology
Leistungssport & #Krebs: Das neu gegründete Deutsche Kompetenzzentrum Leitungssport und Krebs - KLiK der #Uniklinik #Köln und der @SpohoKoeln unterstützt Athletinnen und Athleten, die während ihrer aktiven Karriere an #Krebs erkranken. #CIOABCD https://t.co/P5BGKeEMkx
SUBMIT your work and join us for an exciting meeting on #BMFS incl. #TBD in November in beautiful #Paris 🇫🇷 @ESHaematology @UniklinikAachen #cioabcd @HallekMichael @EHA_Hematology @TheEBMT @dgho_eV @TeamTelomereInc
⏰ #ESHBMFS2024 ABSTRACT SUBMISSION ➡ https://t.co/1SIVd8hIvI
ESH-EBMT-EHA-IPIG 3rd Translational Research Conference: Bone Marrow Failure & Leukaemia Predisposition Syndromes
Chairs: @CarmemBonfim1, @brummendorf, A. Risitano, @SharonSavageMD
#ESHCONFERENCES #ESHSCHOLARSHIPFUND
We are eagerly awaiting your work on acquired and inherited bone marrie failures to be submitted to #ESHBMFS2024: 1 MONTH LEFT TO SUBMIT YOUR ABSTRACT!: https://t.co/rsPzifvLKu See you all in #Paris !!! @ESHaematology @EHA_Hematology @TheEBMT @lichterzellen @AAundPNHeV #cioabcd
CONGRESS #EHA2024 | Peter Borchmann #cioabcd presents the final analysis of phase III #HD21 trial of PET2-individualized BrECADD regimen vs intensified BEACOPP in patients with advanced-stage #HodgkinLymphoma. BrECADD had superior efficacy (PFS 94.3% vs 90.9% at 4 yr) with abbreviated treatment duration and favourable tolerability; BrECADD is recommended as SOC.
#lymphoma #lymsm #MedicalCongress
Prof. Jürgen Wolf, Ärztlicher Leiter des Centrums für Integrierte #Onkologie an der Uniklinik Köln und Experte für #Lungenkrebs beantwortet in der @BILD-#Krebssprechstunde unter Tel.: 0180-246 88 02 noch bis 11:30 Uhr Fragen. @nngmlungcancer #CIOABCD https://t.co/UCenI0nMHS
A beautiful example of how a pilot project by @UniklinikAachen expanded into a Multi-Center CCC such as #cioabcd can lead to meaningful improvements in cancer care ! 🙏 @UniklinikDUS and @UniklinikBonn Effectiveness of a support program for families …https://t.co/NSpt69hbAX
CONGRESS #ASCO24 | Peter Borchmann, MD #cioabcd presented the first report of the final analysis of phase III #HD21 trial of PET2-individualized BrECADD regimen vs intensified BEACOPP in patients with advanced-stage #HodgkinLymphoma. BrECADD had superior efficacy (PFS 94.3% vs 90.9% at 4 yr) with abbreviated treatment duration and favourable tolerability; BrECADD is recommended as SOC for AS-cHL #lymphoma #lymsm
Onkologische Chirurgie im OP-Saal der Zukunft: Welche Perspektiven bieten Robotik, KI und erweiterte Realitäten für die moderne onkologische Chirurgie? Das ist Thema des #CIOABCD-Patiententages am 3. Juni 2024. Mehr erfahren und online teilnehmen: https://t.co/HPPXOCzrZk
Happy to be back today at the comprehensive cancer center of @UniklinikAachen @UniklinikBonn @UKKoeln @UniklinikDUS as external advisor - the „CIO“ is serving a population of 11 M people 🇪🇺
Most Popular Users
Elon Musk 
@elonmusk
241.3M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
113M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.3M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.5M followers
KATY PERRY
@katyperry
89.1M followers
Taylor Swift
@taylorswift13
83M followers
Lady Gaga
@ladygaga
74.5M followers
Virat Kohli
@imvkohli
72M followers
Kim Kardashian
@kimkardashian
70.5M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
65M followers
Bill Gates
@billgates
64.6M followers
The Ellen Show
@theellenshow
62.4M followers
Selena Gomez
@selenagomez
62.2M followers
CNN
@cnn
61.8M followers
X
@x
60.8M followers